BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36269086)

  • 1. Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies.
    Coughlin DG; Hiniker A; Peterson C; Kim Y; Arezoumandan S; Giannini L; Pizzo D; Weintraub D; Siderowf A; Litvan I; Rissman RA; Galasko D; Hansen L; Trojanowski JQ; Lee E; Grossman M; Irwin D
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):953-964. PubMed ID: 36269086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning reveals disease-specific signatures of white matter pathology in tauopathies.
    Vega AR; Chkheidze R; Jarmale V; Shang P; Foong C; Diamond MI; White CL; Rajaram S
    Acta Neuropathol Commun; 2021 Oct; 9(1):170. PubMed ID: 34674762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
    Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease.
    Ando K; Tomimura K; Sazdovitch V; Suain V; Yilmaz Z; Authelet M; Ndjim M; Vergara C; Belkouch M; Potier MC; Duyckaerts C; Brion JP
    Neurobiol Dis; 2016 Oct; 94():32-43. PubMed ID: 27260836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
    Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
    Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M
    Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to demix Alzheimer-type and PSP-type tau lesions out of their mixture -hybrid approach to dissect comorbidity.
    Ebashi M; Ito Y; Uematsu M; Nakamura A; Hirokawa K; Kamei S; Uchihara T
    Acta Neuropathol Commun; 2019 May; 7(1):71. PubMed ID: 31060611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T; Sahara N; Yen SH; Cookson N; Ishizawa T; Hutton M; de Silva R; Lees A; Dickson DW
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):547-56. PubMed ID: 12071638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
    Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
    Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
    Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy.
    Piras A; Collin L; Grüninger F; Graff C; Rönnbäck A
    Acta Neuropathol Commun; 2016 Mar; 4():22. PubMed ID: 26936765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
    Strickland SL; Morel H; Prusinski C; Allen M; Patel TA; Carrasquillo MM; Conway OJ; Lincoln SJ; Reddy JS; Nguyen T; Malphrus KG; Soto AI; Walton RL; Crook JE; Murray ME; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Uitti RJ; Wszolek ZK; Ross OA; Graff-Radford NR; Dickson DW; Ertekin-Taner N
    Acta Neuropathol Commun; 2020 Oct; 8(1):172. PubMed ID: 33092647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Machine Learning-Based Approach to Discrimination of Tauopathies Using [
    Endo H; Tagai K; Ono M; Ikoma Y; Oyama A; Matsuoka K; Kokubo N; Hirata K; Sano Y; Oya M; Matsumoto H; Kurose S; Seki C; Shimizu H; Kakita A; Takahata K; Shinotoh H; Shimada H; Tokuda T; Kawamura K; Zhang MR; Oishi K; Mori S; Takado Y; Higuchi M
    Mov Disord; 2022 Nov; 37(11):2236-2246. PubMed ID: 36054492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.